A detailed history of New Edge Advisors, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 157 shares of BIO stock, worth $51,893. This represents 0.0% of its overall portfolio holdings.

Number of Shares
157
Previous 206 23.79%
Holding current value
$51,893
Previous $56,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $12,934 - $16,887
-49 Reduced 23.79%
157 $52,000
Q2 2024

Aug 15, 2024

SELL
$268.26 - $339.48 $87,184 - $110,331
-325 Reduced 61.21%
206 $56,000
Q1 2024

May 14, 2024

SELL
$304.11 - $351.99 $47,137 - $54,558
-155 Reduced 22.59%
531 $183,000
Q4 2023

Feb 13, 2024

SELL
$269.37 - $365.04 $808 - $1,095
-3 Reduced 0.44%
686 $221,000
Q3 2023

Nov 14, 2023

SELL
$350.25 - $422.63 $839,199 - $1.01 Million
-2,396 Reduced 77.67%
689 $246,000
Q2 2023

Aug 14, 2023

BUY
$359.49 - $486.4 $127,259 - $172,185
354 Added 12.96%
3,085 $1.17 Million
Q1 2023

May 12, 2023

BUY
$418.69 - $503.0 $79,969 - $96,073
191 Added 7.52%
2,731 $1.31 Million
Q4 2022

Feb 14, 2023

BUY
$351.71 - $456.01 $893,343 - $1.16 Million
2,540 New
2,540 $1.07 Million
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $142,683 - $200,034
-272 Closed
0 $0
Q4 2021

Feb 17, 2022

SELL
$708.84 - $794.68 $950,554 - $1.07 Million
-1,341 Reduced 83.14%
272 $206,000
Q3 2021

Oct 29, 2021

BUY
$657.71 - $825.77 $1.06 Million - $1.33 Million
1,613 New
1,613 $1.2 Million
Q1 2021

Apr 26, 2021

SELL
$547.01 - $662.35 $576,548 - $698,116
-1,054 Closed
0 $0
Q4 2020

Jan 27, 2021

BUY
$510.68 - $643.45 $85,283 - $107,456
167 Added 18.83%
1,054 $614,000
Q3 2020

Nov 03, 2020

BUY
$454.43 - $535.6 $403,079 - $475,077
887 New
887 $457,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.14B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.